TURK Drug and Serum Industries, which produces vaccines, serum, dialysis solutions, biological products and medicine, said in a statement late Friday that there is a record demand for the initial public offering (IPO) of the company.
“There has been a 61.9 times more demand than the volume of the public offering,” said Erkan Ünal, the general manager of Oyak Yatırım, a subsidiary of Turkey's military pension fund Oyak.
Ünal also said that there have been 128,000 investors recorded so far.
“There has been 138.6 times more demand than the volume allocated for individual investors,” Ünal added.
Oyak Yatırım officials also said that the value of the total public offering has been TL 234.5 million ($31 million) and has recorded 123,000 investors.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.
